{"groups":[{"description":"Patients receive combination chemotherapy without bortezomib.","id":"FG000","title":"Arm A (Combination Chemotherapy): T-ALL"},{"description":"Patients received combination therapy with bortezomib (4 doses at 1.3mg/m2 during Induction and 4 doses at 1.3mg/m2 during Delayed Intensification)","id":"FG001","title":"Arm B (Combination Chemotherapy, Bortezomib): T-ALL"},{"description":"Patients receive combination chemotherapy without bortezomib.","id":"FG002","title":"Arm A (Combination Chemotherapy): T-LLy"},{"description":"Patients received combination therapy with bortezomib (4 doses at 1.3mg/m2 during Induction and 4 doses at 1.3mg/m2 during Delayed Intensification)","id":"FG003","title":"Arm B (Combination Chemotherapy, Bortezomib): T-LLy"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"9"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"2"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"9"},{"groupId":"FG001","numSubjects":"9"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"4"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"94"},{"groupId":"FG001","numSubjects":"72"},{"groupId":"FG002","numSubjects":"24"},{"groupId":"FG003","numSubjects":"15"}],"type":"Physician Decision"},{"reasons":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"3"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"1"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"8"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"8"}],"type":"Ineligible"},{"reasons":[{"groupId":"FG000","numSubjects":"6"},{"groupId":"FG001","numSubjects":"4"},{"groupId":"FG002","numSubjects":"5"},{"groupId":"FG003","numSubjects":"5"}],"type":"Inevaluable"},{"reasons":[{"groupId":"FG000","numSubjects":"19"},{"groupId":"FG001","numSubjects":"16"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"7"}],"type":"Refusal of further protocol therapy"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"}],"type":"Development of SMN"},{"reasons":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"18"},{"groupId":"FG002","numSubjects":"15"},{"groupId":"FG003","numSubjects":"2"}],"type":"Relapse/Progression"},{"reasons":[{"groupId":"FG000","numSubjects":"5"},{"groupId":"FG001","numSubjects":"5"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}],"type":"VHR T-ALL who have an M2/M3 marrow and/or detectable MRD by end of the 3 HR Intensification Blocks"},{"reasons":[{"groupId":"FG000","numSubjects":"44"},{"groupId":"FG001","numSubjects":"47"},{"groupId":"FG002","numSubjects":"3"},{"groupId":"FG003","numSubjects":"2"}],"type":"Still on Therapy"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"}],"type":"Identified to have Ph+ T-ALL"},{"reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"0"}],"type":"Identified to have Ph+ T-Lly"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"312"},{"groupId":"FG001","numSubjects":"315"},{"groupId":"FG002","numSubjects":"111"},{"groupId":"FG003","numSubjects":"109"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"108"},{"groupId":"FG001","numSubjects":"123"},{"groupId":"FG002","numSubjects":"52"},{"groupId":"FG003","numSubjects":"62"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"204"},{"groupId":"FG001","numSubjects":"192"},{"groupId":"FG002","numSubjects":"59"},{"groupId":"FG003","numSubjects":"47"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}